PE20011272A1 - Combinacion de sustancias activas que contiene montirelina - Google Patents
Combinacion de sustancias activas que contiene montirelinaInfo
- Publication number
- PE20011272A1 PE20011272A1 PE2001000482A PE2001000482A PE20011272A1 PE 20011272 A1 PE20011272 A1 PE 20011272A1 PE 2001000482 A PE2001000482 A PE 2001000482A PE 2001000482 A PE2001000482 A PE 2001000482A PE 20011272 A1 PE20011272 A1 PE 20011272A1
- Authority
- PE
- Peru
- Prior art keywords
- combination
- effect
- intense
- montirelin
- active substances
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMBINACION QUE COMPRENDE: a) MONTIRELINA DE FORMULA I Y b) UN COMPUESTO DE EFECTO OPIODE DE EFECTO DEBIL TAL COMO CODEINA, DEXTROPROPOXIFEN, DIHIDROCODEINA, DIFENOXILATO, ETILMORFINA, MEPTAZINOL, TRAMADOL, PETIDINA, ENTRE OTROS; OPIOIDE DE EFECTO INTENSO TAL COMO BUTORFANOL, DEXTROMORAMIDA, DIACELTILMORFINA, ENTRE OTROS; OPIODE DE EFECTO MUY INTENSO TAL COMO TAL COMO ALFENTANIL, BUPRENORFINA, ETORFINA, FENTANIL, ENTRE OTROS. LA RELACION PONDERAL ENTRE a Y b SE ENCUENTRA EN EL INTERVALO DE 1:10 HASTA 1: 2000 DE PREFERENCIA DE 1: 50. LA FORMULACION SE CARACTERIZA PORQUE AL MENOS UNO DE LOS COMPONENTES DE a) O b) SE ENCUENTRA EN FORMA RETARDADA PRODUCIDA POR UN REVESTIMIENTO RETARDANTE, FIJACION EN UNA RESINA INTERCAMBIADORA IONICA, INCRUSTACION EN UNA MATRIZ RETARDANTE O COMBINACION DE LOS MISMOS. LA COMBINACION ES UTIL PARA EL TRATAMIENTO DE DOLORES INTENSOS, DOLORES CRONICOS, AGUDOS
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10025947A DE10025947A1 (de) | 2000-05-26 | 2000-05-26 | Wirkstoffkombination enthaltend Montirelin und eine Verbindung mit opioider Wirksamkeit |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20011272A1 true PE20011272A1 (es) | 2002-01-26 |
Family
ID=7643551
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2001000482A PE20011272A1 (es) | 2000-05-26 | 2001-05-25 | Combinacion de sustancias activas que contiene montirelina |
Country Status (5)
| Country | Link |
|---|---|
| AR (1) | AR029096A1 (es) |
| AU (1) | AU2001274020A1 (es) |
| DE (1) | DE10025947A1 (es) |
| PE (1) | PE20011272A1 (es) |
| WO (1) | WO2001091733A2 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SA07280459B1 (ar) | 2006-08-25 | 2011-07-20 | بيورديو فارما إل. بي. | أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني |
| WO2011106416A2 (en) * | 2010-02-24 | 2011-09-01 | Cima Labs Inc. | Abuse-resistant formulations |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4426378A (en) * | 1981-04-09 | 1984-01-17 | The United States Of America As Represented By The Secretary Of The Army | Thyrotropin releasing hormone in therapy of shock and as a central nervous system stimulant |
-
2000
- 2000-05-26 DE DE10025947A patent/DE10025947A1/de not_active Withdrawn
-
2001
- 2001-05-10 WO PCT/EP2001/005345 patent/WO2001091733A2/de active Application Filing
- 2001-05-10 AU AU2001274020A patent/AU2001274020A1/en not_active Abandoned
- 2001-05-21 AR ARP010102403A patent/AR029096A1/es unknown
- 2001-05-25 PE PE2001000482A patent/PE20011272A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001091733A2 (de) | 2001-12-06 |
| WO2001091733A3 (de) | 2002-04-04 |
| AR029096A1 (es) | 2003-06-04 |
| AU2001274020A1 (en) | 2001-12-11 |
| DE10025947A1 (de) | 2001-11-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT2004033A (en) | Encapsulated materials | |
| BR0316305A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, métodos para tratar a dor em um animal, para estimular a função do receptor opióide em uma célula, para preparar uma composição, e para tratar diarréia em um animal, composição, e kit | |
| BR0211390A (pt) | Tratamento de infecções da unha com no | |
| IL169425A (en) | Topical stabilized prostaglandin e compound dosage forms | |
| CY1108137T1 (el) | Συνθεση για εισπνευστηρα δοσομετρημενης δοσης που χρησιμοποιει υδρο-φθορο-αλκανια ως προωθητικα | |
| BR9913433A (pt) | Sistema desinfetante estabilizado composto de duas partes e composições e métodos a ele relacionado | |
| RU2009114849A (ru) | Самоконсервирующиеся водные фармацевтические композиции | |
| UY24354A1 (es) | Composiciones farmacéuticas que contienen epinastina | |
| AR046933A1 (es) | Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea | |
| MXPA01012882A (es) | Composiciones y metodos que comprenden gluconato de morfina. | |
| ES2133324T3 (es) | Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y metodos de uso. | |
| TW200501947A (en) | Stabilized pharmaceutical composition comprising an amorphous active substance | |
| NZ547587A (en) | Pharmaceutical compositions and methods for insulin treatment | |
| RU2007119641A (ru) | Композиция, включающая ацетаминофен, кофеин и необязательно аспирин в смеси со щелочным агентом для увеличения абсорбции | |
| UY27203A1 (es) | Bencimidazoles útiles en el tratamiento de la disfunción sexual | |
| PE123899A1 (es) | Formulacion que contiene un opioide en combinacion con un agonista alfa-adrenergico y su utilizacion como analgesico | |
| TW200603742A (en) | Dry composition for oral uptake, and in-use-preparing gel composition for oral uptake | |
| EA200800788A1 (ru) | Фунгицидные смеси на основе триазолов | |
| PE20011272A1 (es) | Combinacion de sustancias activas que contiene montirelina | |
| AR039907A1 (es) | Composiciones cosmeticas con malonatos de amonio | |
| WO2005007118A3 (en) | Treatment or prevention of damage due to radiation exposure | |
| MXPA02010828A (es) | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. | |
| GEP20094648B (en) | Anti-parasiticidal composition | |
| ATE412404T1 (de) | Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon | |
| PE20020041A1 (es) | Combinacion farmaceutica que comprende un compuesto de efecto opioide y un compuesto peptidico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |